Clinical Trials Currently Recruiting Patients

Study: Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

• Indications: Anatomic Stage IV Breast Cancer AJCC v8; ERBB2 Overexpression; HER2 Positive Breast Carcinoma; Metastatic Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8; Refractory Breast Carcinoma

• Phase: Phase I

• More Information: ClinicalTrials.gov - Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer